Literature DB >> 14274970

ASYMPTOMATIC TYPHOIDAL BACTEREMIA IN VOLUNTEERS.

M J SNYDER, R B HORNICK, F R MCCRUMB, L J MORSE, T E WOODWARD.   

Abstract

Keywords:  BACTERIOLOGY; CLINICAL RESEARCH; DIAGNOSIS; IMMUNOLOGY; SEPTICEMIA; TYPHOID

Mesh：

Substances：

Year:  1963        PMID： 14274970

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  4 in total

1.  Salmonella enterica Serovar Typhi Lipopolysaccharide O-Antigen Modification Impact on Serum Resistance and Antibody Recognition.

Authors:  Erica Kintz; Christian Heiss; Ian Black; Nicholas Donohue; Naj Brown; Mark R Davies; Parastoo Azadi; Stephen Baker; Paul M Kaye; Marjan van der Woude
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

2.  Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.

Authors:  Malick M Gibani; Celina Jin; Sonu Shrestha; Maria Moore; Lily Norman; Merryn Voysey; Elizabeth Jones; Luke Blackwell; Helena Thomaides-Brears; Jennifer Hill; Christoph J Blohmke; Hazel C Dobinson; Philip Baker; Claire Jones; Danielle Campbell; Yama F Mujadidi; Emma Plested; Lorena Preciado-Llanes; Giorgio Napolitani; Alison Simmons; Melita A Gordon; Brian Angus; Thomas C Darton; Vincenzo Cerundulo; Andrew J Pollard
Journal:  PLoS Negl Trop Dis       Date:  2020-10-20

3.  An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.

Authors:  Claire S Waddington; Thomas C Darton; Claire Jones; Kathryn Haworth; Anna Peters; Tessa John; Ben A V Thompson; Simon A Kerridge; Robert A Kingsley; Liqing Zhou; Kathryn E Holt; Ly-Mee Yu; Stephen Lockhart; Jeremy J Farrar; Marcelo B Sztein; Gordon Dougan; Brian Angus; Myron M Levine; Andrew J Pollard
Journal:  Clin Infect Dis       Date:  2014-02-10       Impact factor: 9.079

4.  Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.

Authors:  Celina Jin; Malick M Gibani; Maria Moore; Helene B Juel; Elizabeth Jones; James Meiring; Victoria Harris; Jonathan Gardner; Anna Nebykova; Simon A Kerridge; Jennifer Hill; Helena Thomaides-Brears; Christoph J Blohmke; Ly-Mee Yu; Brian Angus; Andrew J Pollard
Journal:  Lancet       Date:  2017-09-28       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.